Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development

被引:2
作者
Wayhelova, Marketa [1 ,2 ,6 ]
Vallova, Vladimira [1 ,2 ]
Broz, Petr [1 ,3 ,4 ]
Mikulasova, Aneta [5 ]
Loubalova, Dominika [1 ]
Filkova, Hana [2 ]
Smetana, Jan [1 ]
Drabova, Klara [6 ]
Gaillyova, Renata [6 ]
Kuglik, Petr [1 ,2 ]
机构
[1] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic
[2] Univ Hosp Brno, Ctr Mol Biol & Genet, Dept Internal Med Haematol & Oncol, Lab Cytogen, Brno, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Brno, Czech Republic
[4] Fac Hosp Moto, Brno, Czech Republic
[5] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[6] Univ Hosp Brno, Dept Med Genet & Genom, Brno, Czech Republic
关键词
MUTATIONS;
D O I
10.1038/s10038-021-00988-w
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pathogenic sequence variant in the GNAI1 gene were recently introduced as a cause of novel syndrome with a manifestation of variable developmental delay and autistic features. In our study, we report a case of monozygotic twins with severe intellectual disability and motor delay and developmental dysphasia. Both probands and their parents were examined using multi-step molecular diagnostic algorithm including whole-exome sequencing (WES), resulting in the identification of a novel, de novo pathogenic sequence variant in the GNAI1 gene, NM_002069.6:c.815 A>G, p.(Asp272Gly) in probands. Using WES we also verified the microarray findings of a familial 8q24.23q24.3 duplication and heterozygous 5q13.2 deletion, not associated with clinical symptoms in probands. Our results confirmed the role of the GNAI1 gene in the pathogenesis of syndromic neurodevelopmental disorders. They support trio- or quatro-based WES as a suitable molecular diagnostics method for the simultaneous detection of clinically relevant sequence variants and CNVs in individuals with neurodevelopmental disorders and rare diseases.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [31] 46,ΧΥ DSD in an adolescent with a novel de novo variant of the NR5A1 gene - case report and literature review
    Kostopoulou, Eirini
    Eliades, Andreas
    Papatheodoropoulou, Alexia
    Sertedaki, Amalia
    Sinopidis, Xenophon
    Tzelepi, Vasiliki
    Jang, Seokhui
    Seo, Go Hun
    Chrysis, Dionysios
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025, 24 (01): : 275 - 281
  • [32] Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1
    Yang, Lisha
    Fu, Jiewen
    Cheng, Jingliang
    Zhou, Baixu
    Chen, Maomei
    Anuchapreeda, Songyot
    Fu, Junjiang
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [33] Severe mitochondrial encephalomyopathy caused by de novo variants in OPA1 gene
    Di Nottia, Michela
    Rizza, Teresa
    Baruffini, Enrico
    Nesti, Claudia
    Torraco, Alessandra
    Diodato, Daria
    Martinelli, Diego
    Dal Canto, Flavio
    Gilea, Alexandru Ionut
    Zoccola, Martina
    Siri, Barbara
    Dionisi-Vici, Carlo
    Bertini, Enrico
    Santorelli, Filippo Maria
    Goffrini, Paola
    Carrozzo, Rosalba
    FRONTIERS IN GENETICS, 2024, 15
  • [34] De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability
    Wijnen, Iris G. M.
    Veenstra-Knol, Hermine E.
    Vansenne, Fleur
    Gerkes, Erica H.
    de Koning, Tom
    Vos, Yvonne J.
    Tijssen, Marina A. J.
    Sival, Deborah
    Darin, Niklas
    Vanhoutte, Els K.
    Oosterloo, Mayke
    Pennings, Maartje
    van de Warrenburg, Bart P.
    Kamsteeg, Erik-Jan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (06) : 763 - 769
  • [35] Novel phenotype associated with homozygous likely pathogenic variant in the POP1 gene
    Michelson, Marina
    Yosovich, Keren
    Bahar, Sarit
    Yogev, Yuval
    Birk, Ohad S.
    Ginzberg, Mira
    Lev, Dorit
    CLINICAL GENETICS, 2024, 105 (06) : 671 - 675
  • [36] Next-generation sequencing for identifying a novel/de novo pathogenic variant in a Mexican patient with cystic fibrosis: a case report
    Martinez-Hernandez, Angelica
    Larrosa, Julieta
    Barajas-Olmos, Francisco
    Garcia-Ortiz, Humberto
    Mendoza-Caamal, Elvia C.
    Contreras-Cubas, Cecilia
    Mirzaeicheshmeh, Elaheh
    Luis Lezana, Jose
    Orozco, Lorena
    BMC MEDICAL GENOMICS, 2019, 12 (1)
  • [37] De novo pathogenic DNM1L variant in a patient diagnosed with atypical hereditary sensory and autonomic neuropathy
    Tarailo-Graovac, Maja
    Zahir, Farah R.
    Zivkovic, Irena
    Moksa, Michelle
    Selby, Kathryn
    Sinha, Sunita
    Nislow, Corey
    Stockler-Ipsiroglu, Sylvia G.
    Sheffer, Ruth
    Saada-Reisch, Ann
    Friedman, Jan M.
    van Karnebeek, Clara D. M.
    Horvath, Gabriella A.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (10):
  • [38] Novel variant in HDAC8 gene resulting in the severe Cornelia de Lange phenotype
    Jezela-Stanek, Aleksandra
    Pienkowski, Victor Murcia
    Jurkiewicz, Dorota
    Iwanicka-Pronicka, Katarzyna
    Jedrzejowska, Maria
    Krajewska-Walasek, Malgorzata
    Ploski, Rafal
    CLINICAL DYSMORPHOLOGY, 2019, 28 (03) : 124 - 128
  • [39] Skeletal abnormalities, pediatric-onset severe osteoporosis, and multiple fragility fractures in a patient with a novel CTNNB1 de novo variant
    Lesnyak, Olga
    Marini, Francesca
    Sokolnikova, Polina
    Sorokina, Margarita
    Sukhareva, Kseniya
    Artamonova, Irina
    Kenis, Vladimir
    Tkach, Olga
    Kostareva, Anna
    Brandi, Maria Luisa
    BONE REPORTS, 2024, 21
  • [40] A de novo FBN1 missense variant associated with a severe phenotype of early onset Marfan syndrome
    Markholt, Sara
    Skaerbaek, Jens
    Munk, Kim
    Andersen, Brian N.
    Lilballe, Dorte L.
    Blechingberg, Jenny
    Petersen, Jesper P.
    V. Bjerre, Jesper
    Gregersen, Pernille A.
    Kyng, Kasper J.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2024, 75